Humana Inc (HUM) Earnings: 2Q Adjusted EPS Surpasses Estimates, Revenue Hits $29.54 Billion

Humana Inc on Smartkarma

Analysts at Baptista Research on Smartkarma are closely monitoring Humana Inc, a significant player in the health insurance industry. According to their report titled “Humana Inc.: Enhanced Strategic Management of Benefit Costs and Member Acquisition Tactics! – Major Drivers,” Humana has shown a mixed performance in the first quarter of 2024. Despite this, the company has adjusted its expectations for the upcoming year, reaffirming its full-year adjusted EPS guidance at around $16. With an increase in membership growth outlook from 100,000 to 150,000 net additions, Humana is displaying operational resilience and strategic expansions. The report highlights positive medical cost trends and growth in their primary care business, indicating a strong performance.

In another report by Baptista Research, titled “Humana Inc.: Impacts on Pharmacy Benefit Managers (PBMs) Resulting From IRA Changes & Other Major Drivers,” Humana’s first quarter results for 2024 were analyzed. CEO Bruce Broussard and CFO Susan Diamond provided insights during a Q&A session following the earnings call. Broussard emphasized Humana’s solid start in 2024, confirming the company’s full-year adjusted earnings per share (EPS) guidance at approximately $16. The report sheds light on the company’s financial performance and future outlook, showing a positive sentiment towards Humana’s growth trajectory and strategic decisions in the industry.

A look at Humana Inc Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Humana Inc. is positioned with a promising long-term outlook. With a high momentum score of 4, the company is showing strong performance trends that may continue in the future. This indicates positive market sentiment and potential growth opportunities for investors.

Moreover, Humana Inc. received above-average scores in value, growth, and resilience, all at a level of 3. This suggests that the company is considered to have solid fundamentals and is well-positioned for sustainable growth. However, with a dividend score of 2, investors may not see significant returns in terms of dividends. Overall, based on these scores, Humana Inc. seems to be a company with growth potential and strong market momentum worth keeping an eye on for the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma